产品编号：G601510
产品规格：50mg
产品价格：面议
| 标准品编号: | G601510 |
| 名称: | GDC-0941 |
| 别名: | 2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinothieno[3,2-d]pyrimidine; 4-[2-(1H-Indazol-4-yl)-6-[[4-(methylsulfonyl)piperazin-1-yl]methyl]thieno[3,2-d]pyrimidin-4-yl]morpholine; GDC 0941; GDC 941; GNE 0941; Pictilisib; Pictrelisib |
| CAS号: | 957054-30-7 |
| 分子式: | C₂₃H₂₇N₇O₃S₂ |
| 外观: | 白色至白色固体 |
| 熔点: | >200ºC (dec.) |
| 分子量: | 513.64 |
| 储存: | -20°C Freezer |
| 溶解度: | DMSO (Slightly), Methanol (Slightly, Heated) |
| 种类: | Research Tools; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | GDC-0941 is a potent and selective oral inhibitor of the class I PI3K. GDC-0941 demonstrated broad spectrum of activity in breast, ovarian, lung, and prostate cancer models. Studies has also shown GDC-0941 may enhance anti-tumor activity of Docetaxel (D494420) in human breast cancer models. Potent PI3K inhibitor. |
| 参考文献 | |
